CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
91 hedge funds and large institutions have $1.49B invested in China Biologic Products Holdings, Inc. in 2018 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 20 increasing their positions, 35 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
3% less call options, than puts
Call options by funds: $8.24M | Put options by funds: $8.5M
43% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 35
Holders
91
Holding in Top 10
2
Calls
$8.24M
Puts
$8.5M
Top Buyers
| 1 | +$48.3M | |
| 2 | +$19.8M | |
| 3 | +$10.7M | |
| 4 |
PHK
Point72 Hong Kong
Hong Kong
|
+$10.3M |
| 5 |
Man Group
London,
United Kingdom
|
+$7.95M |
Top Sellers
| 1 | -$72.9M | |
| 2 | -$60.3M | |
| 3 | -$50.9M | |
| 4 |
BlackRock
New York
|
-$40.5M |
| 5 |
CGI
Comgest Global Investors
Paris,
France
|
-$39.1M |